Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 60 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 57 58 59 60 presentations: 1 to 50 of 2972
WELCOME AND SESSION OVERVIEW: PROGRAM COMMITTEE WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES   (ABSTRACT 1a)
Nicolas Chomont
Université de Montréal, Montreal, Canada
Serena S Spudich
Yale University, New Haven, CT, USA
from CROI 2021 on March 6, 2021 10:00 AM-2:00 PM
ADVANCES IN MOLECULAR VIROLOGY OF HIV AND SARS-COV-2
Frank Kirchhoff
Ulm University Medical Center, Ulm, Germany
from CROI 2021 on March 6, 2021 10:00 AM-2:00 PM
ADVANCES IN HIV AND SARS-COV-2 IMMUNOLOGY
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
from CROI 2021 on March 6, 2021 10:00 AM-2:00 PM
ADVANCES IN COVID-19 TREATMENT STRATEGIES AND CONTROLLING THE EPIDEMIC
Jürgen K Rockstroh
Medizinische Universitatsklini, Bonn, Germany
from CROI 2021 on March 6, 2021 10:00 AM-2:00 PM
ADVANCES IN BIOMEDICAL PREVENTION OF HIV
Jean-Michel Molina
University of Paris, Paris, France
from CROI 2021 on March 6, 2021 10:00 AM-2:00 PM
ADVANCES IN HIV CURE
Katharine J Bar
University of Pennsylvania, Philadelphia, PA, USA
from CROI 2021 on March 6, 2021 10:00 AM-2:00 PM
GENERAL Q&A AND SESSION WRAP-UP
Nicolas Chomont
Université de Montréal, Montreal, Canada
Serena S Spudich
Yale University, New Haven, CT, USA
from CROI 2021 on March 6, 2021 10:00 AM-2:00 PM
CHAIRS WELCOME TO VIRTUAL CROI 2021
Sharon L. Hillier
University of Pittsburgh Medical Center, Pittsburgh, PA, USA
from CROI 2021 on March 7, 2021 10:00 AM-12:05 PM
INTRODUCTION TO THE MARTIN DELANEY PRESENTATION
James Pickett
AIDS Foundation of Chicago, Chicago, IL, USA
from CROI 2021 on March 7, 2021 10:00 AM-12:05 PM
VACCINE NATIONALISM IS KILLING US: HOW INEQUITIES IN RESEARCH AND ACCESS TO SARS-COV-2 VACCINES WILL PERPETUATE THE PANDEMIC   (ABSTRACT 2a)
Gregg S. Gonsalves
Yale University, New Haven, CT, USA
Fatima Hassan
Health Justice Initiative, Cape Town, South Africa
from CROI 2021 on March 7, 2021 10:00 AM-12:05 PM
INTRODUCTION TO THE BERNARD FIELDS LECTURE
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
from CROI 2021 on March 7, 2021 10:00 AM-12:05 PM
NEUTRALIZING ANTIBODIES AGAINST CORONAVIRUSES   (ABSTRACT 3)
Pamela J Bjorkman
California Institute of Technology, Pasadena, CA, USA
from CROI 2021 on March 7, 2021 10:00 AM-12:05 PM
INTRODUCTION TO THE N'GALY-MANN LECTURE
Elaine J Abrams
Columbia University, New York, NY, USA
Tedros Adhanom Ghebreyesus
World Health Organization, Geneva, Switzerland
from CROI 2021 on March 7, 2021 10:00 AM-12:05 PM
LESSONS FROM THE CONCURRENT HIV/AIDS AND COVID-19 PANDEMICS: A TWO-WAY STREET   (ABSTRACT 4)
Anthony S Fauci
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
from CROI 2021 on March 7, 2021 10:00 AM-12:05 PM
SESSION OVERVIEW
Robert T Schooley
University of California San Diego, La Jolla, CA, USA
David L Thomas
The Johns Hopkins School of Medicine, Baltimore, MD, USA
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
RAPID GENOMIC SEQUENCING FOR MANAGEMENT OF COVID-19   (ABSTRACT 11)
Kwok-Yung Yuen
The University of Hong Kong, Hong Kong, Hong Kong
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
COVID-19: A HOSPITALISED UNWELL PATIENT WITH PNEUMONITIS   (ABSTRACT 12)
Sanjay Bhagani
Royal Free Hospital, London, United Kingdom
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
CRITICAL CARE OF COVID-19   (ABSTRACT 13)
Janhavi Athale
Mayo Clinic Arizona, Phoenix, AZ, USA
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
QUESTIONS AND ANSWERS WITH THE AUDIENCE
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
SESSION OVERVIEW
Susan P Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
Richard E Chaisson
The Johns Hopkins University, Baltimore, MD, USA
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
MAKING SENSE OF STUDY DESIGN DIFFERENCES BETWEEN COVID-19 PLATFORM TRIALS   (ABSTRACT 9)
Lori Dodd
National Institutes of Health, Bethesda, MD, USA
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
DESIGN OF CURRENT AND FUTURE COVID-19 VACCINE EFFICACY TRIALS   (ABSTRACT 10)
Holly Janes
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
LIVE QUESTIONS AND ANSWERS WITH THE AUDIENCE
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
SESSION OVERVIEW
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
Frank Kirchhoff
Ulm University Medical Center, Ulm, Germany
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
STRUCTURES OF SARS-COV-2 ANTIBODIES INDUCED BY INFECTION AND MRNA VACCINES   (ABSTRACT 5)
Christopher O Barnes
California Institute of Technology, Pasadena, CA, USA
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
EMERGING CONCEPTS IN HIV-1 RESTRICTION   (ABSTRACT 6)
Edward Campbell
Loyola University Chicago, Maywood, IL, USA
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
SARS-COV-2 SPECIFIC AND CROSS-REACTIVE T CELL RESPONSES   (ABSTRACT 7)
Daniela Weiskopf
La Jolla Institute for Immunology, La Jolla, CA, USA
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
ARTIFICIAL INTELLIGENCE-INSPIRED ANTIBODY ENGINEERING   (ABSTRACT 8)
Sai Reddy
ETH Zurich, Basel, Switzerland
from CROI 2021 on March 7, 2021 12:20 PM-2:20 PM
DOES HIV IMPACT COVID-19 SUSCEPTIBILITY OR SEVERITY?   (ABSTRACT 31)
Julia Del Amo
Ministry of Health, Madrid, Spain
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
THE IMPACT OF COVID-19 ON THE HIV PANDEMIC WORLDWIDE   (ABSTRACT 32)
Andrew D Kambugu
Makerere University, Kampala, Uganda
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
THE IMPACT OF COVID-19 BEYOND HIV   (ABSTRACT 33)
Helen Bygrave
International AIDS Society, London, United Kingdom
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
FEAR AND COVID-19: EXPERIENCES ON THE GROUND   (ABSTRACT 34)
Francois Venter
Ezintsha, Johannesburg, South Africa
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
FROM GENOME TO FUNCTION: PHENOTYPIC CHARACTERISATION OF PANDEMIC SARS-COV-2 VARIANTS   (ABSTRACT 23)
Volker Thiel
University of Bern, Bern, Switzerland
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
IMMUNE EVASION STRATEGIES BY SARS-COV-2: NSP1 AND BEYOND   (ABSTRACT 24)
Konstantin Sparrer
Ulm University, Ulm, Germany
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
SHARED VULNERABILITIES AND DIFFERENT COUNTERMEASURES OF HIV AND SARS-COV-2   (ABSTRACT 25)
Eric O Freed
National Cancer Institute, Frederick, MD, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
IMMUNE RESPONSES TO SARS-COV-2   (ABSTRACT 26)
Akiko Iwasaki
Yale University, New Haven, CT, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
SYMPOSIUM CONVENER
Wesley I Sundquist
University of Utah School of Medicine, Salt Lake City, UT, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
LIVE-CELL IMAGING: CAPSID TRAFFICKING TO THE NUCLEUS   (ABSTRACT 19)
Barbara Müller
University Hospital Heidelberg, Heidelberg, Germany
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
LIVE-CELL IMAGING OF HIV-1 NUCLEAR IMPORT, UNCOATING, AND PROVIRUSES   (ABSTRACT 20)
Vinay K Pathak
National Cancer Institute, Frederick, MD, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
VISUALIZATION OF HIV-1 CAPSID-DEPENDENT REPLICATION IN VITRO   (ABSTRACT 21)
Barbie Ganser-Pornillos
University of Virginia, Charlottesville, VA, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
LENACAPAVIR (GS-6207): FIRST CLINICALLY ACTIVE LONG-ACTING INHIBITOR OF HIV CAPSID   (ABSTRACT 22)
Tomas Cihlar
Gilead Sciences, Inc, Foster City, CA, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
THE POTENTIAL OF LONG-ACTING INJECTABLE DRUGS FOR PREVENTION AND TREATMENT OF TUBERCULOSIS   (ABSTRACT 27)
Eric Nuermberger
Johns Hopkins University, Baltimore, MD, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
PREGNANCY, HIV, AND TUBERCULOSIS: CURRENT PRACTICES AND RESEARCH OPPORTUNITIES   (ABSTRACT 28)
Jyoti S Mathad
Weill Cornell Medical College, New York, NY, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
ADVANCES IN PEDIATRIC TUBERCULOSIS PREVENTION AND TREATMENT   (ABSTRACT 29)
Nicole Salazar-Austin
Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
IMPACT OF COVID-19 PANDEMIC ON HIV AND TUBERCULOSIS: WHO PERSPECTIVE   (ABSTRACT 30)
Souyma Swaminathan
World Health Organization, Geneva, Switzerland
from CROI 2021 on March 8, 2021 12:00 AM-12:00 AM
WELCOME AND DAILY ROADMAP
Sharon L. Hillier
University of Pittsburgh Medical Center, Pittsburgh, PA, USA
from CROI 2021 on March 8, 2021 10:00 AM-11:00 AM
IMAGING VIRAL LIFE CYCLES   (ABSTRACT 14)
Hans-Georg Kräusslich
Heidelberg University, Heidelberg, Germany
Wesley I Sundquist
University of Utah School of Medicine, Salt Lake City, UT, USA
from CROI 2021 on March 8, 2021 10:00 AM-11:00 AM
DISPARITIES IN HEALTH: FROM HIV TO COVID-19 AND BEYOND   (ABSTRACT 15)
James E.K. Hildreth
Meharry Medical College, Nashville, TN, USA
Carlos del Rio
Emory University, Atlanta, GA, USA
from CROI 2021 on March 8, 2021 10:00 AM-11:00 AM
INTRODUCTION OF SPEAKERS (PART I)
Judith S Currier
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
SHORT-COURSE ALENDRONATE FOR THE PREVENTION OF ART-ASSOCIATED BONE LOSS   (ABSTRACT 96)
Tara McGinty
University College Dublin, Dublin, Ireland
from CROI 2021 on March 8, 2021 11:15 AM-1:15 PM
<< first | < prev page: of 60 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 57 58 59 60 presentations: 1 to 50 of 2972